Category Archives: MS Treatment

Todays approval is the culmination of more than a decade of work by Genzyme to develop Lemtrada, said Genzyme President and CEO, David Meeker. Lemtrada demonstrated superior efficacy over Rebif on annualized relapse rates in the two studies which were the basis for approval. A comprehensive risk evaluation and mitigation strategy (REMS) will be instituted in order to help detect and manage the serious risks identified with treatment. The FDA approval of Lemtrada is based on two pivotal randomized Phase III open-label rater-blinded studies comparing treatment with Lemtrada to Rebif (high-dose subcutaneous interferon beta-1a) in patients with relapsing remitting MS who were either new to treatment (CARE-MS I) or who had relapsed while on prior therapy (CARE-MS II). In CARE-MS I, Lemtrada was significantly more effective than interferon beta-1a at reducing annualized relapse rates; the difference observed in slowing disability progression did not reach statistical significance. In CARE-MS II, Lemtrada was significantly more effective than interferon beta-1a at reducing annualized relapse rates, and accumulation of disability was significantly slowed in patients given Lemtrada vs. interferon beta-1a. The clinical development program for Lemtrada involved nearly 1,500 patients with more than 6,400 patient-years of safety follow-up. The unmet need in MS remains … Continue reading →

The judge granted the care order for the baby to Tusla until June 30th, 2017, after hearing submissions. Photograph: Alan Betson Tusla, the Child and Family Agency, has been granted a two and a half year care order for a baby boy born earlier this year to a young woman at the centre of the latest abortion controversy. A judge granted the care order for the baby to Tusla until June 30th, 2017, after hearing submissions from lawyers for Tusla, the childs mother, Ms Y, and a Guardian ad Litem appointed by the courts to represent the interests of the child. Tusla had sought a 12-month care order to allow the agency to reassess the situation in a years time and this was not opposed by barrister, Esther Early and solicitor, Caoimhe Haughey, who represented the childs mother, Ms Y. The court heard that both Ms Early and Ms Haughey had been in contact with Ms Y, but were unable to obtain instructions from her with regard to the Tusla application to seek a year-long care order at the expiry of an interim two-month care order granted in September. A solicitor for the Guardian ad Litem also made an application … Continue reading →

The judge granted the care order for the baby to Tusla until June 30th, 2017, after hearing submissions. Photograph: Alan Betson Tusla, the Child and Family Agency, has been granted a two and a half year care order for a baby boy born earlier this year to a young woman at the centre of the latest abortion controversy. A judge granted the care order for the baby to Tusla until June 30th, 2017, after hearing submissions from lawyers for Tusla, the childs mother, Ms Y, and a Guardian ad Litem appointed by the courts to represent the interests of the child. Tusla had sought a 12-month care order to allow the agency to reassess the situation in a years time and this was not opposed by barrister, Esther Early and solicitor, Caoimhe Haughey, who represented the childs mother, Ms Y. The court heard that both Ms Early and Ms Haughey had been in contact with Ms Y, but were unable to obtain instructions from her with regard to the Tusla application to seek a year-long care order at the expiry of an interim two-month care order granted in September. A solicitor for the Guardian ad Litem also made an application … Continue reading →

Unhappy daughter: Kambah resident Moira Smith looks at a photo of her father Douglas who died recently. Photo: Rohan Thomson A dying elderly Canberran received such poor treatment at the Canberra Hospital during his last week of life, he begged his daughter to come and take him away. Kambah resident Moira Smith said her father wasn't "treated like a person" during his five-day stay at the hospital and, by the end, she was determined he would leave. She has registered a complaint with the Human Rights Commission over her father's treatment and sent a letter to Health Minister Katy Gallagher. Ms Smith said she had been looking after her father, who suffered from chronic arthritis, for eight years before he was placed in the Goodwin retirement community in Farrer. Advertisement He was referred to Canberra Hospital in August after being diagnosed with flu and pneumonia which was present in the Goodwin community. Yet after just a few days in Canberra Hospital, the once-enthusiastic man told his daughter, "It's all meaningless. I just want to die." "I just cannot get it out of my head. The misery of those last few days and my helplessness to do anything about it," she … Continue reading →

Federal regulators have approved an injectable multiple sclerosis drug developed by Cambridge biotech Genzyme 10 months after it was initially rejected. Genzyme announced the approval of Lemtrada, a medication to treat patients with relapsing forms of the debilitating disease, last night. Todays approval is the culmination of more than a decade of work by Genzyme to develop Lemtrada, Genzyme President and CEO David Meeker said in a statement. A comprehensive risk evaluation and mitigation strategy will be instituted in order to help detect and manage the serious risks identified with treatment. Lemtrada, which is already sold in Europe, was rejected by the FDA last December after medical experts raised concerns about its safety and the quality of clinical studies. Two new studies comparing Lemtrada to EMD Seronos drug Rebif in patients with relapsing remitting MS who were either new to treatment or who had relapsed while on prior therapy prompted the FDAs course reversal after Lemtrada demonstrated superior efficacy over Rebif on annualized relapse rates, Meeker said. Multiple sclerosis is a chronic, autoimmune condition that affects more than 2 million people worldwide and up to 400,000 in the United States. The FDA approval of Lemtrada is a significant milestone for … Continue reading →

New York, New York (PRWEB) November 13, 2014 Allen Bowling, MD, PhD, internationally renowned neurologist and specialist in lifestyle and alternative medicine, encourages MS patients to consider lifestyle and unconventional medical approaches to achieve better health and well-being. Three big areas that are often neglected are exercise, diet, and personal well-being, says Dr. Bowling. These areas are especially important for optimal health because they may impact the disease process of MS, MS symptoms, and also other medical conditions that may adversely affect MS. In his new book, "Optimal Health with Multiple Sclerosis," Dr. Bowling outlines his Seven Step Approach to integrating lifestyle, alternative, and conventional medicine and he explains over 50 safe and effective lifestyle strategies that may help optimize health and quality of life, including simple diet and exercise tips, as well as the benefits of dietary supplements and herbs. Dr. Bowling explains, Some of these methods empower people by allowing them to use their body's own resources for therapeutic effects. For example, exercise in conventional as well as unconventional forms, such as tai chi, yoga, and Pilates, may improve multiple MS symptoms and may even impede the disease process itself. Dietary approaches such as vitamin D and generally … Continue reading →

avid Osmond kicked off the opening ceremony at the Walk MS: Houston event on Sunday, Nov. 10. For David, the fundraising event for the National Multiple Sclerosis Society was part of his personal mission to bring more awareness to MS diagnosis and treatment. Both he and his father, Alan, have been diagnosed with MS. ]]> The younger Osmond recently wrote I Can Do This, a song to inspire other people living with MS. The song is available as a free download at the Our Voice in Song website. Osmond partnered with Novaris Pharmaceuticals to create the website to share diet and fitness tips and help educate people about Relapsing MS. There are four types of MS. Alan Osmond was diagnosed with Progressive MS. As the name implies, it generally progresses until the person relies on a wheelchair. With Relapsing MS, an attack may last weeks, months or years, then go away for months or years. Since he was diagnosed with Relapsing MS at age 26, Osmond has become an advocate for the MS community. If theres one thing I want people to know, Osmond said, its that there is hope, and there is community. There is support and unconditional love. … Continue reading →

Ground breaking deal provides new access for thousands of New Zealanders to medical treatments Multiple sclerosis (MS), chronic obstructive pulmonary disease (COPD), chronic myeloid leukaemia (CML) asthma, cystic fibrosis, Parkinsons and Alzheimers among disease targets in major Novartis-PHARMAC deal Auckland, Friday 10th October 2014. New Zealanders will gain new access to the highest number of medicines and targeted treatment areas ever agreed in a single arrangement under a deal jointly announced by PHARMAC and Novartis today. Collectively, an estimated 300,000*[1]-5 New Zealanders stand to benefit from new access to treatments or expanded treatment options. Welcoming the deal as a ground breaking example of what can be achieved when industry and PHARMAC work together, Tim Jones, Novartis Country Group Manager, New Zealand, said the treatments would give patients more options and in some cases make a vital difference to managing very serious conditions. The deal covers new access to nine treatments for diseases including multiple sclerosis (MS), chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, Parkinsons and Alzheimers. A further six products provide an expanded range of treatment options. Access to Gilenya (fingolimod) for patients with relapsing remitting multiple sclerosis (RRMS) will provide an oral treatment for the first time. It … Continue reading →

EMMA BAILEY KEEPING POSITIVE: Gareth Ford will soon receive new medication for his multiple sclerosis. Gareth Ford thought it was his years of motocross catching up on him, when his limbs started going numb. It was 2009 and he was a busy father of two working as a truck driver. "I was a typical Kiwi male. I refused to go to the doctor and then my left leg stopped working altogether. Prior to that I had the usual seizures where your eyesight goes and your sight is foggy." He finally went to the doctor and was diagnosed with multiple sclerosis, an auto immune disease that affects the central nervous system including the brain, spinal cord and optic nerves. There are approximately 4000 people in New Zealand diagnosed with MS. "I had ridden motocross for 17 years before that and I thought [the MS symptoms] were my sporting lifestyle catching up on me. "I had been a truck driver for 18 years, as well as my motocross, and in 2004 had been ranked third in the world competing as a body builder. It really did turn my whole life upside down. "I went though depression, I lost my partner of five … Continue reading →

Diet with Treating Multiple Sclerosis Now we talk about multiple sclerosis treatment,multiple sclerosis symptoms,symptoms of multiple sclerosis,multiple sclerosis society,multiple sclerosis diagnosis,multiple sclerosis prognosis,treatm... By: joly zoom … Continue reading →